2BBBullish & Bearish
Health Care

Bristol (BMY) Stock Score & Signals

Bristol (BMY) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - General industry. Its current 2BB score is 51 out of 100.

About Bristol

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to t...

2BB score and signals

Bristol’s current 2BB score is 51 out of 100, built from the signal categories below.

SignalScoreReading
Activity50Moderate
Momentum54Stable
Financial strength68Strong
Quality100Very Strong
Risk35Low

Company facts

CEOChris Boerner
HeadquartersNew York, New York, United States
Founded1887
Employees32.5K
P/E ratio14.75
52-week range$42.52 – $68.64

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-031.6034$12.74B
2026-10-291.74$12.68B
2026-07-301.5976$11.85B
2026-04-301.581.4311$11.49B$11.02B